WPI 2345 (Lacosamide 200 mg)
Pill with imprint WPI 2345 is Blue, Elliptical / Oval and has been identified as Lacosamide 200 mg. It is supplied by Actavis Pharma, Inc..
Lacosamide is used in the treatment of seizures; epilepsy and belongs to the drug class miscellaneous anticonvulsants. Risk cannot be ruled out during pregnancy. Lacosamide 200 mg is classified as a Schedule 5 controlled substance under the Controlled Substance Act (CSA).
Images for WPI 2345
Lacosamide
- Imprint:
- WPI 2345
- Strength:
- 200 mg
- Color:
- Blue
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 5 - Some potential for abuse
- Labeler / Supplier:
- Actavis Pharma, Inc.
- National Drug Code (NDC):
- 00591-2345
More about lacosamide
- Lacosamide Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- En Español
- 106 Reviews
- Drug class: miscellaneous anticonvulsants
Consumer resources
- Lacosamide oral/injection
- Lacosamide Injection
- Lacosamide Oral Solution
- Lacosamide Tablets
- Lacosamide (Advanced Reading)
- Lacosamide Intravenous (Advanced Reading)
Other brands: Vimpat
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
